| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |